Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 202,527 |
|
|||||
| News | - | ||||||
| Day High | 7.06 | Low High |
|||||
| Day Low | 6.80 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Verrica Parmaceuticals Inc | VRCA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.16 | -2.27% | 6.90 | 16:30:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 7.06 | 6.80 | 7.06 | 6.90 | 7.06 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,954 | 202,527 | $ 6.96 | $ 1,409,021 | - | 2.86 - 7.755 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:02:04 | 65 | $ 6.90 | USD |
Verrica Parmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 293.11M | 42.42M | - | 5.12M | -67M | -1.58 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Verrica Parmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VRCA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.19 | 7.20 | 6.75 | 6.97 | 132,654 | -0.29 | -4.03% |
| 1 Month | 5.00 | 7.32 | 4.78 | 6.28 | 180,151 | 1.90 | 38.00% |
| 3 Months | 5.49 | 7.32 | 4.60 | 5.77 | 130,818 | 1.41 | 25.68% |
| 6 Months | 3.60 | 7.51 | 2.86 | 5.91 | 626,749 | 3.30 | 91.67% |
| 1 Year | 6.33 | 7.755 | 2.86 | 5.75 | 462,968 | 0.57 | 9.00% |
| 3 Years | 12.50 | 14.789 | 1.77 | 5.67 | 263,021 | -5.60 | -44.80% |
| 5 Years | 10.56 | 18.67 | 1.77 | 6.68 | 192,849 | -3.66 | -34.66% |
Verrica Parmaceuticals Description
| Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts. |
